Korean scientists discover plant ingredients against Covid-19

Jung Hee-young and Minu Kim 2022. 11. 10. 11:12
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Aster koraiensis and deodeok [Source : IBS]
Scientists in South Korea have found that some commonly used local foods or herbal medicines contain ingredients that prevent the Covid-19 virus from entering and infecting human cells.

The Institute for Basic Science (IBS) said on Wednesday its research team led by Dr. Lee Chang-jun, Head of Life Science Research Cluster, demonstrated that lancemaside A, a major triterpenoid saponin from Codonopsis lanceolata, and astersaponin I from Aster koraiensis inhibit an infection of SARS-CoV-2.

The Covid-19 virus enters human cells through membrane fusion between the viral membrane and the host cell membrane. But the Dr. Lee’s team found that the natural ingredients block this fusion, inhibiting all infection routes of the virus and syncytium formation. Infection was suppressed to almost the same level not only for SARS-CoV-2, but also for its variants like Omicron, according to the research team.

Lancemaside A and astersaponin I have a long sugar chain structure very similar to cholesterol, which is a major component of cell membranes. Human cell membranes accept the chain’s central part, while leaving the long chain part protruded out of the cell membrane, which blocks the membrane fusion between the coronavirus and human cells.

Earlier, the research team jointly with an Institut Pasteur Korea team found that Platycodin D, a natural component of Platycodon grandiflorum, has activity against Covid-19.

Codonopsis lanceolata known as deodeok in Korean, Aster koraiensis and ginseng products expose the upper respiratory epithelial cell to high concentrations of their ingredients and the pharmacological action of these ingredients may be effective in asymptomatic or early-stage patients, said Dr. Lee.

Most of the conducted studies are at in vitro stage, but the research team expects to go further through in vivo and clinical trials.

By Jung Hee-young and Minu Kim

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?